This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignee: Pfizer Corporation. Active years: 2000-2001.
Company Filing History:
Years Active: 2000-2001
Title: Shane Allen Eisenbeis: Innovator in Pharmaceutical Chemistry
Introduction
Shane Allen Eisenbeis is a notable inventor based in Pawcatuck, CT (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly in the synthesis of compounds that interact with GABAa receptors. With a total of 2 patents, his work is recognized for its innovative approaches to drug development.
Latest Patents
Eisenbeis's latest patents include a method of synthesis of pyrrole amides. This method involves preparing pyrrole-carboxyamides that selectively bind to GABAa receptors. The process comprises reacting 1,3-cycloakane-diones with bromoethylacetate, followed by a reaction with an acid halide, an aromatic amine, and finally with an ammonium source at elevated temperatures. Another patent focuses on processes and intermediates for preparing substituted indazole, showcasing his expertise in complex chemical synthesis.
Career Highlights
Shane Allen Eisenbeis is currently employed at Pfizer Corporation, a leading global pharmaceutical company. His work at Pfizer has allowed him to contribute to the development of innovative therapeutic solutions. His research is pivotal in advancing the understanding of drug interactions and synthesis.
Collaborations
Eisenbeis has collaborated with notable colleagues, including Stephane Caron and John Anthony Ragan. These collaborations have fostered a productive environment for innovation and research within the pharmaceutical sector.
Conclusion
Shane Allen Eisenbeis exemplifies the spirit of innovation in pharmaceutical chemistry through his patents and contributions at Pfizer Corporation. His work continues to impact the field significantly, paving the way for future advancements in drug development.